Biomeme
Philadelphia
About Biomeme
Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The system enables users to isolate DNA, analyze it using lab technology, and manage results in the cloud. It facilitates mobile testing at the point-of-need for healthcare, agriculture, vector surveillance, veterinary medicine, environmental monitoring, and education and citizen science. Biomeme was developed by Biomeme Inc., a Philadelphia-based company co-founded by Max Perelman, Jesse vanWestrienen, and Marc DeJohn in 2012.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $50K – $100K
- Total funding: $1.4M
- Last round: Convertible Note (Mar 2024)
- Website: biomeme.com
- Phone: 415-295-5246
Industries & Categories
Biotechnology, Health Care, mHealth, Security
Social Profiles
Canonical: https://fsome.com/organization/biomeme-136752 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.